Search for: "AMGEN INC."
Results 441 - 460
of 704
Sort by Relevance
|
Sort by Date
27 Aug 2012, 6:11 am
Ct. 1414 (2012)--relating to the statute of limitations under Section 16 of the Securities and Exchange Act of 1934, and granted review in two other cases--Amgen, Inc. v. [read post]
27 Aug 2012, 6:11 am
Ct. 1414 (2012)--relating to the statute of limitations under Section 16 of the Securities and Exchange Act of 1934, and granted review in two other cases--Amgen, Inc. v. [read post]
24 Aug 2012, 4:33 pm
Relying on our decision in Amgen Inc. v. [read post]
23 Aug 2012, 1:35 pm
Amgen, Inc. v. [read post]
22 Aug 2012, 3:26 pm
Among other things, Weissman worked the exclusive Bohemian Grove in Northern California and “pitched” Bill Bowes, a co-founder of Amgen, who, along with his wife, gave $1.3 million to the campaign. [read post]
16 Aug 2012, 2:00 am
Ct. 1414 (2012)–relating to the statute of limitations under Section 16 of the Securities and Exchange Act of 1934, and granted review in two other cases–Amgen, Inc. v. [read post]
9 Aug 2012, 5:00 am
Amgen (IDE Embrel) Deposition2005-06-10 Saban v. [read post]
7 Aug 2012, 7:27 am
CAFC: A Divisional By Any Other Name Is Not a DivisionalThe Federal Circuit, in Amgen Inc. v. [read post]
5 Aug 2012, 9:04 pm
” Citing Amgen Inc. v. [read post]
27 Jul 2012, 11:44 am
See Amgen Inc. v. [read post]
23 Jul 2012, 5:36 pm
Behrend — court power to allow a class-action lawsuit if the possibility of class-wide damages award is in doubt (grant limited to question as rewritten by the Court) 11-1085 – Amgen Inc. [read post]
18 Jul 2012, 4:52 am
" "The second is that it is necessary to distinguish between claims that are difficult to construe or that have a "fuzzy boundary" (in the words of Lord Hoffmann in Kirin-Amgen Inc v Hoechst Marion Roussel Ltd [2004] UKHL 46, [2005] RPC 9 at [126]) on the one hand from claims that are truly ambiguous on the other. [read post]
17 Jul 2012, 10:05 am
The lawsuit was initially filed in 2002 by Ivey Woodard, a former employee of Amgen, the drug maker that sells Epogen. [read post]
17 Jul 2012, 8:30 am
Amgen, Inc. v. [read post]
11 Jul 2012, 10:22 am
Michael Petty, the former vice president of development and regulatory law at biotechnology company Amgen Inc., joins King & Spalding in its Washington office. [read post]
11 Jul 2012, 5:53 am
Despite denying any wrongdoing, Denver-based Davita Inc., a kidney dialysis chain, has settled a Texas lawsuit related to its use of Epogen, an anemic drug made by Amgen. [read post]
9 Jul 2012, 5:04 pm
Amgen Inc., 660 F.3d 1170 (9th Cir., 11/8/11), the Ninth Circuit Court of Appeals discussed the fraud-on-the-market presumption of reliance in securities fraud class actions. [read post]
9 Jul 2012, 3:00 pm
The whistleblower in this case, Ivey Woodard, is a former employee of Amgen: the maker of Epogen. [read post]
9 Jul 2012, 2:00 am
The following is an excerpt from the June 2012 edition of the Alert: This month’s Alert discusses the Supreme Court’s grant of certiorari in Amgen, Inc. v. [read post]
9 Jul 2012, 2:00 am
The following is an excerpt from the June 2012 edition of the Alert: This month’s Alert discusses the Supreme Court’s grant of certiorari in Amgen, Inc. v. [read post]
